• Jean-Pierre Droz, Matti Aapro, Lodovico Balducci, Helen Boyle, Thomas Van den Broeck, Paul Cathcart, Louise Dickinson, Eleni Efstathiou, Mark Emberton, John M Fitzpatrick, Axel Heidenreich, Simon Hughes, Steven Joniau, Michael Kattan, Nicolas Mottet, Stéphane Oudard, Heather Payne, Fred Saad, and Toru Sugihara.
• Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France. Electronic address: jpdroz@orange.fr.
• Lancet Oncol.. 2014 Aug 1;15(9):e404-14.

AbstractIn 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013, a new multidisciplinary SIOG working group was formed to update these recommendations. The consensus of the task force is that older men with prostate cancer should be managed according to their individual health status, not according to age. On the basis of a validated rapid health status screening instrument and simple assessment, the task force recommends that patients are classed into three groups for treatment: healthy or fit patients who should have the same treatment options as younger patients; vulnerable patients with reversible impairment who should receive standard treatment after medical intervention; and frail patients with non-reversible impairment who should receive adapted treatment.Copyright © 2014 Elsevier Ltd. All rights reserved.

34 keywords...

hide…